BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

551 related articles for article (PubMed ID: 32460624)

  • 1. The amount of cytokine-release defines different shades of Sars-Cov2 infection.
    Bindoli S; Felicetti M; Sfriso P; Doria A
    Exp Biol Med (Maywood); 2020 Jun; 245(11):970-976. PubMed ID: 32460624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine Storms: Understanding COVID-19.
    Mangalmurti N; Hunter CA
    Immunity; 2020 Jul; 53(1):19-25. PubMed ID: 32610079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pro- and Anti-Inflammatory Responses in Severe COVID-19-Induced Acute Respiratory Distress Syndrome-An Observational Pilot Study.
    Notz Q; Schmalzing M; Wedekink F; Schlesinger T; Gernert M; Herrmann J; Sorger L; Weismann D; Schmid B; Sitter M; Schlegel N; Kranke P; Wischhusen J; Meybohm P; Lotz C
    Front Immunol; 2020; 11():581338. PubMed ID: 33123167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The COVID-19 Cytokine Storm; What We Know So Far.
    Ragab D; Salah Eldin H; Taeimah M; Khattab R; Salem R
    Front Immunol; 2020; 11():1446. PubMed ID: 32612617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Storm, typhoon, cyclone or hurricane in patients with COVID-19? Beware of the same storm that has a different origin.
    Alunno A; Carubbi F; Rodríguez-Carrio J
    RMD Open; 2020 May; 6(1):. PubMed ID: 32423970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine storm intervention in the early stages of COVID-19 pneumonia.
    Sun X; Wang T; Cai D; Hu Z; Chen J; Liao H; Zhi L; Wei H; Zhang Z; Qiu Y; Wang J; Wang A
    Cytokine Growth Factor Rev; 2020 Jun; 53():38-42. PubMed ID: 32360420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 infection: The role of cytokines in COVID-19 disease.
    Costela-Ruiz VJ; Illescas-Montes R; Puerta-Puerta JM; Ruiz C; Melguizo-Rodríguez L
    Cytokine Growth Factor Rev; 2020 Aug; 54():62-75. PubMed ID: 32513566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can Beta-2-Adrenergic Pathway Be a New Target to Combat SARS-CoV-2 Hyperinflammatory Syndrome?-Lessons Learned From Cancer.
    Barbieri A; Robinson N; Palma G; Maurea N; Desiderio V; Botti G
    Front Immunol; 2020; 11():588724. PubMed ID: 33117402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokines and COVID-19: friends or foes?
    Rokni M; Hamblin MR; Rezaei N
    Hum Vaccin Immunother; 2020 Oct; 16(10):2363-2365. PubMed ID: 32841579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Characteristics and Immune Injury Mechanisms in 71 Patients with COVID-19.
    Wu Y; Huang X; Sun J; Xie T; Lei Y; Muhammad J; Li X; Zeng X; Zhou F; Qin H; Shao L; Zhang Q
    mSphere; 2020 Jul; 5(4):. PubMed ID: 32669467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine storm and COVID-19: a chronicle of pro-inflammatory cytokines.
    Fara A; Mitrev Z; Rosalia RA; Assas BM
    Open Biol; 2020 Sep; 10(9):200160. PubMed ID: 32961074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cytokine super cyclone in COVID-19 patients with risk factors: the therapeutic potential of BCG immunization.
    Johnson BS; Laloraya M
    Cytokine Growth Factor Rev; 2020 Aug; 54():32-42. PubMed ID: 32747157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Covid-19: Perspectives on Innate Immune Evasion.
    Taefehshokr N; Taefehshokr S; Hemmat N; Heit B
    Front Immunol; 2020; 11():580641. PubMed ID: 33101306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 triggers inflammatory responses and cell death through caspase-8 activation.
    Li S; Zhang Y; Guan Z; Li H; Ye M; Chen X; Shen J; Zhou Y; Shi ZL; Zhou P; Peng K
    Signal Transduct Target Ther; 2020 Oct; 5(1):235. PubMed ID: 33037188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview: Systemic Inflammatory Response Derived From Lung Injury Caused by SARS-CoV-2 Infection Explains Severe Outcomes in COVID-19.
    Polidoro RB; Hagan RS; de Santis Santiago R; Schmidt NW
    Front Immunol; 2020; 11():1626. PubMed ID: 32714336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine release syndrome in severe COVID-19.
    Moore JB; June CH
    Science; 2020 May; 368(6490):473-474. PubMed ID: 32303591
    [No Abstract]   [Full Text] [Related]  

  • 17. The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease.
    McGonagle D; Sharif K; O'Regan A; Bridgewood C
    Autoimmun Rev; 2020 Jun; 19(6):102537. PubMed ID: 32251717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 and multiorgan failure: A narrative review on potential mechanisms.
    Mokhtari T; Hassani F; Ghaffari N; Ebrahimi B; Yarahmadi A; Hassanzadeh G
    J Mol Histol; 2020 Dec; 51(6):613-628. PubMed ID: 33011887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Could hemophagocytic lymphohistiocytosis be the core issue of severe COVID-19 cases?
    Opoka-Winiarska V; Grywalska E; Roliński J
    BMC Med; 2020 Jul; 18(1):214. PubMed ID: 32664932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of monocytes and macrophages to the local tissue inflammation and cytokine storm in COVID-19: Lessons from SARS and MERS, and potential therapeutic interventions.
    Jafarzadeh A; Chauhan P; Saha B; Jafarzadeh S; Nemati M
    Life Sci; 2020 Sep; 257():118102. PubMed ID: 32687918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.